Scarica l'app Stockscreener
84.38
0.54%
-0.46
Dopo l'orario di chiusura:
84.00
-0.38
-0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$84.84
Aprire:
$86.32
Volume 24 ore:
5.06M
Relative Volume:
1.32
Capitalizzazione di mercato:
$33.81B
Reddito:
$3.95B
Utile/perdita netta:
$680.80M
Rapporto P/E:
50.53
EPS:
1.67
Flusso di cassa netto:
$535.00M
1 W Prestazione:
+8.51%
1M Prestazione:
+8.46%
6M Prestazione:
-26.38%
1 anno Prestazione:
-32.74%
Intervallo 1D:
$83.89
$86.33
Intervallo di 1 settimana:
$73.62
$86.33
Portata 52W:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
84.38 | 33.81B | 3.95B | 680.80M | 535.00M | 1.67 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Wealthcare Advisory Partners LLC Has $998,000 Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Sees Significant Decline in Short Interest - MarketBeat
DexCom raised to outperform by Baird - MSN
Dexcom inks glucose biosensor partnership with Life Time - Drug Delivery Business News
DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5 years - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Sax Wealth Advisors LLC - MarketBeat
Avanza Fonder AB Takes Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Legacy Wealth Asset Management LLC Acquires New Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback - Seeking Alpha
Woodstock Corp Cuts Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom (NASDAQ:DXCM) Stock Price Up 3.7%Here's What Happened - MarketBeat
JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight - MedTech Dive
Baird R W Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy - MarketBeat
Latin America Continuous Glucose Monitoring Device Market Projected To Witness Substantial Growth, - EIN News
Fifth Third Wealth Advisors LLC Has $477,000 Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Oak Thistle LLC - MarketBeat
DexCom (NASDAQ:DXCM) Stock Unloaded Rep. Kevin Hern - MarketBeat
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook - MSN
Why DexCom, Inc. (DXCM) Is Skyrocketing - Insider Monkey
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom raised to outperform by Baird (DXCM:NASDAQ) - Seeking Alpha
Piper Sandler bullish on DexCom shares citing growth potential and new catalysts - MSN
Baird raises DexCom stock to outperform, target to $104 - MSN
Expert Outlook: DexCom Through The Eyes Of 11 Analysts - Benzinga
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Outlook Wealth Advisors LLC Buys New Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom (NASDAQ:DXCM) Upgraded by Robert W. Baird to Outperform Rating - MarketBeat
2 Healthcare Stocks to Buy Hand Over Fist in January - Yahoo Finance
DexCom, Inc. (NASDAQ:DXCM) Holdings Decreased by Assenagon Asset Management S.A. - MarketBeat
180 Wealth Advisors LLC Invests $255,000 in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Dexcom CEO talks Stelo sensor launch, OTC strategy - MedTech Dive
Earnings Summary: DexCom reports preliminary Q4 2024 results - AlphaStreet
JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue - Yahoo Finance
DexCom revenue increases 8% in Q4 2024 - Medical Buyer
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - MSN
DexCom (NASDAQ:DXCM) Shares Gap UpShould You Buy? - MarketBeat
CHICAGO TRUST Co NA Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom stock rises on 2025 outlook - MSN
DexCom stock gains, sees 14% revenue growth in 2025 By Investing.com - Investing.com Canada
DexCom stock gains, sees 14% revenue growth in 2025 - Investing.com India
DexCom stock rises on 2025 outlook (NASDAQ:DXCM) - Seeking Alpha
DexCom Q4 Revenue Hits $1.1B as International Sales Surge 17%, Sets Ambitious 2025 Growth Target - StockTitan
DexCom price target raised to $89 from $86 at Bernstein - MSN
Abbott, Dexcom End UPC Feud Over Glucose Monitor Patent - Law360
DexCom (NASDAQ:DXCM) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
42,021 Shares in DexCom, Inc. (NASDAQ:DXCM) Bought by Watts Gwilliam & Co. LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Purchased by First Hawaiian Bank - MarketBeat
Diversified Trust Co Lowers Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)’s Earnings Miss and Competitive Challenges? - Insider Monkey
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):